Valiant Laboratories

Valiant Laboratories Working Capital

The Working Capital of Valiant Laboratories (VALIANTLAB.NS) as of Nov 4, 2026 is 152.71 M INR. In the previous year, Working Capital was 1.35 B INR — a change of -88.69% (lower).

Working Capital

152.71 MINR

YoY

-88.69%

Last updated:

Working Capital of Valiant Laboratories is 2026 152.71 M INR. Working Capital of Valiant Laboratories was 2025 1.35 B INR. It decreases by -88.69% lower compared to the previous year.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Valiant Laboratories Stock analysis

What does Valiant Laboratories do? Valiant Laboratories Ltd manufactures paracetamol API/bulk drug for pharmaceutical applications, targeting medical conditions such as headache, muscle ache, arthritis, back ache, toothache, cold, and fever. The company operates a single manufacturing facility at Tarapur industrial estate, approximately 150 km from Nhava Sheva Port (JNPT), producing specialty chemicals and pharma intermediates for domestic and international markets. Its subsidiary, VALIANT ADVANCED SCIENCES PRIVATE LIMITED, supports the company's operations in the pharmaceutical sector. The firm's primary revenue comes from selling paracetamol API and specialty chemicals to pharmaceutical companies and distributors globally. Manufacturing focuses on high-demand applications like pain relief and fever treatment, with products distributed across India and abroad. The company leverages its Tarapur facility's proximity to Nhava Sheva Port for efficient export logistics. Valiant Laboratories Ltd serves the pharmaceutical industry by supplying essential active ingredients, particularly paracetamol, which is widely used in over-the-counter medications. The company's manufacturing capabilities for specialty chemicals and pharma intermediates cater to both domestic and international clients seeking reliable API sources. Its single-location production model ensures focused resource allocation for consistent output quality. Valiant Laboratories is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Valiant Laboratories stock

Working Capital of Valiant Laboratories is 152.71 M INR in 2026.

Working Capital of Valiant Laboratories changed from 1.35 B INR to 152.71 M INR, representing a -88.69% change. The value is lower than the previous year.

On Eulerpool you can find the complete historical development of Working Capital Valiant Laboratories since 2006 – with annual values, charts, and detailed analysis.

Working capital is the difference between current assets and current liabilities. Positive working capital indicates a company can meet its short-term obligations.

Working Capital's INR is a key factor for investors. Changes in this metric can signal improving or deteriorating fundamentals, directly impacting the stock price. On Eulerpool, you can track Working Capital's Valiant Laboratories historically and in real time.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Balance Sheet — Valiant Laboratories

All Key Metrics — Valiant Laboratories